RecruitingNCT02023060
Functional and Quality of Life Improvement Following Transcatheter Heart Valve Implantation
Sponsor
Sheba Medical Center
Enrollment
100 participants
Start Date
Nov 1, 2013
Study Type
OBSERVATIONAL
Conditions
Summary
The objective is to observe trends in patient characteristics and outcomes after aortic or mitral transcatheter heart valve replacement over time.
Eligibility
Min Age: 18 YearsMax Age: 110 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a new treatment for people with aortic stenosis and trans catheter aortic valve. The study is currently recruiting participants at 5 locations. People eligible for this study include aged 18 Years to 110 Years.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(5)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02023060
Related Trials
Isolated Surgical Aortic Valve Replacement in Low Risk AS Patients
NCT0692415137 locations
Association Between Changes in Aortic Valve Area and Pulmonary Congestion After Transcatheter Aortic Valve Implantation
NCT07794436
CAPTURE-2: Controlled Arterial Protection to Ultimately Remove Embolic Material
NCT072767113 locations
TRanscatheter Aortic-Valve Implantation Without On-site Cardiac Surgery
NCT076044023 locations
Improved Outcomes With Pre-Procedure Shockwave IVL of Common Femoral Artery Access Site Prior to Large Bore Access and Pre-Closure
NCT072050681 location